Total Funding
55
69
Total FundingGrant raised
Growth Score
-5 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36346
MiMedx Group is a wound care and a therapeutic biologics company.
Parker H. Petit: Chairman and CEOPast Role: Matria Healthcare, President & CEO
Rebeccah J. C. Brown: Vice President of Product Development, Regulatory Affairs, and Quality AssurancePast Role: MiMedx Group, Director of Research and Development & Vice President of Operations
About the Company
MiMedx Group developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. They processes the human placental tissue utilizing its proprietary purion process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal
sterilization.
